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To test the hypothesis that an episode of upper respiratory tract infection or 
heterologous immunisation is a predisposing factor for the occurrence of meningococcal 
disease, data from 377 cases of meningococcal disease and their household contacts 
(n = 1124) were analysed by conditional logistic regression analysis with stratification for 
household. The odds ratio for a recent upper respiratory tract infection for patients 
versus household contacts, adjusted for age and the presence of an underlying 
predisposing disease, was 2.8 and that for recent heterologous immunisation 1.0. These 
results support previous observations regarding the association between a preceding 
upper respiratory tract infection and the occurrence of meningococcal disease; however, 
no association was found between preceding heterologous immunisation and meningo- 
coccal disease. Therefore, increased alertness after heterologous immunisation does not 
seem warranted. 
Introduction 
Meningococcal disease still poses major health pro- 
blems in both developing and industrialised countries. 
The high case-fatality rates and significant sequelae 
resulting from this disease continue to be of consid- 
erable concern. Notwithstanding the scientific progress 
that has been made in knowledge of Neisseria 
meningitidis, the reason why the majority of individuals 
who acquire meningococci become carriers, and only a 
minority develop a life-threatening disease, remains 
obscure. 
Several factors have been recognised as risk factors for 
the occurrence of meningococcal disease. These factors 
include young age (due to low titres of bactericidal 
antibodies), male gender, diseases that compromise the 
immunological defence mechanisms (including com- 
plement deficiencies), low socio-economic status, 
crowding, passive smoking and environmental factors 
[ 1-41. Many reports have demonstrated that a preced- 
ing upper respiratory tract infection due to influenza A, 
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other viruses or Mycoplasma pneumoniae is a predis- 
posing factor for the occurrence of meningococcal 
disease [ 5 - 81. Heterologous immunisation may be 
associated with the occurrence of invasive bacterial 
disease (including meningococcal disease); however, 
reports on this subject have been conflicting [9-131. 
During a nationwide survey in the Netherlands from 
1989 to 1990, data were collected from cases of 
meningococcal disease and their household contacts 
[14]. This data set made it possible to analyse the 
association between recent upper respiratory tract 
infection and heterologous immunisation, and the 
occurrence of meningococcal disease. 
Patients and methods 
This study included all consecutive patients with 
meningococcal disease, from whom the causative 
meningococcus or other diagnostic material had been 
forwarded to the Netherlands Reference Laboratory for 
Bacterial Meningitis in Amsterdam between 1 April 
1989 and 30 April 1990. For logistic reasons the study 
was interrupted during the summer months from July 
to September 1989. 
During the study period 509 patients with meninogo- 
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coccal disease were reported. Two co-primary cases, 
who were admitted to hospital within a few hours after 
the primary patient, and five secondary cases, who 
were admitted 2-35 days after the primary patient, 
were excluded from the analysis [14], leaving 502 
eligible cases of meningococcal disease. In 471 
patients, N .  meningitidis was isolated from the 
cerebrospinal fluid (CSF) or blood or both, in nine 
patients the diagnosis was based on the presence of 
meningococcal capsular polysaccharide antigens in the 
CSF and in 22 patients there was a clinical syndrome 
of meningitis or septicaemia with fever and a petechial 
rash, considered to be meningococcal disease by the 
attending physician. 
Persons who slept in the same house as the patient 
during the week prior to hospital admission of the 
patient were considered as household contacts. Every 
patient and household was visited by a regional Public 
Health Officer as soon as possible after hospital 
admission of the patient. Socio-demographic data 
(including the composition of the household) and 
information concerning the presence of predisposing 
diseases, recent use of antibiotics, a recent episode of 
upper respiratory tract infection and recent immunisa- 
tion were collected by means of a questionnaire. The 
questionnaires pertaining to subjects of young age were 
filled out by a parent or a guardian of the subject. 
Predisposing diseases for meningococcal disease were 
defined as the presence of malignancy, immunosuppres- 
sive therapy, diabetes mellitus, chronic obstructive lung 
disease, chronic renal failure, liver cirrhosis, intra- 
venous drug abuse, recent severe head injury and a 
history of neurosurgery. 
A recent episode of upper respiratory tract infection 
was defined as the occurrence of symptoms of a 
common cold, a sore throat, ‘flu’, ear infection or 
bronchitis in the 4 weeks prior to hospital admission of 
the patient. 
A subject was considered to be recently immunised if 
one of the following vaccines had been administered in 
the 4 weeks prior to hospital admission: diphtheria 
toxoid, polio, tetanus toxoid and pertussis vaccine 
(DPTP); measles, mumps and rubella vaccine (MMR); 
tetanus toxoid, typhoid, hepatitis B or influenza 
vaccine. 
Analysis was done by multiple conditional logistic 
regression with stratification for household. The fol- 
lowing potential confounders were addressed: age, 
gender, the presence of a predisposing disease and 
use of antibiotics during the 4 weeks prior to hospital 
admission of the patient. To enhance statistical ef- 
ficiency, age was classified post hoc into seven 
functional categories which represented homogeneous 
age groups with respect to the occurrence of meningo- 
coccal disease. The age categories were <1 year, 1 
year, 2-4, 5-14, 15-19, 20-49 and 250 years, 
respectively. Indicator variables were constructed for 
each age category and the category 20-49 years served 
as the reference category. The effect of recent 
immunisation was analysed in two different logistic 
models. In the first model, an indicator term for recent 
immunisation with any of the above-mentioned vac- 
cines was used (model 1). In the second model, two 
indicator terms were constructed, the first indicator 
pertaining to recent immunisation with a vaccine that 
included the measles component (MMR) and the 
second indicator referring to all other types of 
vaccines. 
All analyses were performed with the statistical 
packages SPSSR and EGRETR. 
Results 
Of the 502 eligible patients, 19 were living alone. Data 
were obtained from 377 of the remaining 483 patients 
(response rate 78.1%) and their household contacts 
(n = 1124). The median number of household contacts 
per patient was 3 (range 1-15). 
The distribution of the various potential confounders 
and study variables among cases and household 
contacts is shown in Table 1. The distribution of 
gender was similar in both groups. The age distribution 
of patients and household contacts differed substan- 
tially, patients being younger on the average. Cases 
were suffering more often from a predisposing disease 
and had used antibiotics prior to hospital admission 
slightly more often than the household contacts. 
During the 4 weeks prior to admission of the patient to 
hospital, an upper respiratory tract infection had been 
present in 134 of the patients (35.5%) and in 216 of the 
household contacts (1 9.2%), and heterologous immu- 
nisation in 36 (9.5%) and 29 (2.6%), respectively 
(Table 1). The type of vaccine which had been 
administered is shown in Table 2. 
The inclusion of gender and recent use of antibiotics 
into the logistic models did not change the estimated 
coefficients of the study variables substantially and 
were left out of the model. In both logistic models, the 
odds ratio for a recent upper respiratory tract infection 
of patients versus household contacts was 2.8 (95% 
confidence interval [95% CI] 1.8-4.2), adjusted for age 
and the presence of a predisposing disease in the 
conditional logistic regression analysis, with stratifica- 
tion for household. In model 1, the odds ratio for 
recent immunisation with any vaccine was 1.0 (95% 
CI: 0.5-2.2). When separate indicator terms for recent 
immunisation with MMR and other vaccines were used 
(model 2), the odds ratio for recent immunisation with 
MMR was 0.8 (95% CI: 0.2-2.9) and that for any 
other type of vaccine was 1.1 (95% CI: 0.5-2.7). 
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Table 1.  Distribution of potential confounders and study variables among 377 cases of meningococcal disease and 
their household contacts (n = 1124) 
Number of subjects/total number of subjects (%) 
Patients Household contacts Variable 
Potential confounders 
Age ca tegoj  (years) 
< 1  
1 
2 -4 
5-14 
15-19 
20-49 
250 
Male gender 
Predisposing disease present 
Recent use of antibiotics* 
Study variables 
Recent upper respiratory tract infection* 
Recent heterologous immunisation* 
381377 
401377 
791377 
1121377 
601377 
321377 
161377 
1971377 
201374 
161350 
(10.1) 
(2 1 .O) 
(8.5) 
(4.2) 
(52.3) 
(5.3) 
(4.6) 
(10.6) 
(29.7) 
(15.9) 
1911 124 
1211 124 
8111 124 
2021 1 124 
10611 124 
65111 124 
5311 124 
5841 1 124 
3611 121 
4111 121 
1341377 (35.5) 21611 124 (19.2) 
361377 (9.5) 2911 119 (2.6) 
*During the 4 weeks prior to hospital admission of the patient. 
Table 2. Type of vaccine administered to cases of 
meningococcal disease and household contacts during 
the 4 weeks before hospital admission of the patient 
Number of recipients 
Vaccine Patients Households contacts 
(n = 36) (n = 29) 
DPTP 22 I5 
MMR 11 2 
DPTP and MMR 2 7 
Tetanus toxoid 0 1 
Typhoid 1 0 
Hepatitis B 0 1 
Influenza 0 2 
Not indicated 0 1 
Discussion 
This report addresses the association of recent upper 
respiratory tract infection or immunisation, and the 
occurrence of meningococcal disease. The analysis was 
done by comparing cases of meningococcal disease and 
their household contacts in a matched analysis with 
stratification for household. In this way, cases and 
household contacts were matched on a number of 
important covariates, such as socio-economic status, 
crowding, environmental factors, genetic factors, pas- 
sive smoking and season. The presence of a predis- 
posing disease and age were important confounders 
which had to be adjusted for in the analysis. As 
expected, the age distributions of the two groups 
differed substantially; however, there was sufficient 
overlap of the age distributions of patients and 
household contacts to enable the adjustment for age 
in the multivariate analysis. 
The response rate of the households during the survey 
was 78.1%. It is not likely that non-response led to 
differential reporting of the events under study. Another 
possible limitation of the study is recall bias. It is 
possible that individuals who had been hospitalised 
recently because of a severe disease might be more 
likely to recall events in their lives preceding that 
disease than healthy contacts. However, this is unlikely 
to pertain to the recall of recent immunisation, because 
this procedure will have a significant impact on a 
subject’s perception. Information bias might be present 
regarding the recall of a recent upper respiratory tract 
infection. However, it is likely that cases and their 
household contacts would have a more similar attitude 
to, and recall of, the events under study than cases and 
controls who were selected from different populations 
(and who were not family members). In addition, in 
many instances the parent or a guardian of a subject of 
young age (who constituted the majority of the cases), 
filled out the questionnaire. In those circumstances it is 
unlikely that there would be a different recall of a 
recent upper respiratory tract infection. If recall bias 
was a problem in the present study, the odds ratio for a 
recent upper respiratory tract infection of patients with 
meningococcal disease versus household contacts 
might be overestimated. 
The results of the present study support previous 
observations regarding the association between an 
upper respiratory tract infection and the occurrence of 
meningococcal disease [ 5 - 81. This predisposing effect 
has been explained by several mechanisms, including 
damage to the mucosal surfaces by the respiratory 
pathogen facilitating the invasion of the meningococcus 
into the bloodstream, and a temporary suppression of 
the immune system due to the viral infection. The latter 
mechanism may also play a role in the relationship 
between meningococcal disease and preceding hetero- 
logous immunisation, although no significant associa- 
tion was found. There was only a small number of 
recently immunised subjects in this study (36 patients 
and 29 household contacts), and lack of power might 
be one reason for not finding an association. However, 
in both logistic models the point estimates of the odds 
ratios of recent immunisation were near to the neutral 
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value of 1. Thus, if this study population is considered 
to be representative, the presence of a real effect was 
not very likely. The finding of a ‘protective’ odds ratio 
of 0.8 for recent immunisation with MMR in model 2 
(although not statistically significant) was unusual and 
does not seem plausible. Indeed the measles component 
of MMR especially is thought to cause irnmuno- 
suppression [15-161. However, it should be borne in 
mind that the statistical methods that have been applied 
are based on large sample theory. As these calculations 
were based on only 13 patients and nine household 
contacts with recent MMR immunisation, the point 
estimate may be unreliable and the ‘protective’ odds 
ratio should be interpreted with caution. Studies with a 
larger number of recently immunised subjects are 
needed to refbte or verify these findings. 
The results regarding the effect of recent immunisation 
are in accordance with the findings of three other case- 
control studies [ 1 1 - 1 31. However, in a double-blind 
placebo-controlled efficacy study of two acellular 
pertussis vaccines, four vaccinated children died during 
follow-up as a result of invasive bacterial disease. The 
authors had no plausible explanation for this finding 
[lo]. They analysed a subset of the study population 
but could not find any indication of immunosuppres- 
sion in vaccine recipients. Finally, in an observational 
study of 82 children, more infectious episodes occurred 
during the month following DTP immunisation com- 
pared with the month before immunisation [9]. No 
control group was included in this study and the 
influence of potential confounding factors cannot be 
excluded. 
It is concluded that heterologous immunisation does 
not seem to be related to the occurrence of meningo- 
coccal disease, but that an upper respiratory tract 
infection enhances the risk of meningococcal disease. 
The exact mechanism by which this occurs cannot be 
deduced from this study. Damage to the mucosal 
surfaces, as postulated before by others, seems to be a 
likely explanation for this increased risk [ 5 -81. 
Increased alertness after heterologous immunisation 
may not be warranted. 
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